Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006449 220016143 1.68 67.56 Curative (C) 2017-06-15 2017-06-18 AML 19 TRIAL N N 220030320 AML19 TRIAL
220006450 220002486 1.83 57.6 Curative (C) 2015-09-10 2015-09-10 AML 19 TRIAL 01 N 220030327 AML19 TRIAL
220006451 220002486 1.61 56.6 Curative (C) 2014-09-04 2014-09-05 AML 19 TRIAL null null 220030327 AML19 TRIAL
220006452 220002486 null null null 2015-10-25 2015-10-25 Nilotinib N N 220030327 NILOTINIB
220006453 220002487 1.78 0 Palliative (P) 2015-04-25 2015-04-25 Nilotinib N Y 220030332 NILOTINIB
220006454 220002487 1.61 0 Disease modification (D) 2015-11-20 2015-11-20 Nilotinib 02 N 220030332 NILOTINIB
220006455 220002488 1.62 58.5 Curative (C) 2013-12-08 2013-12-12 AML Interim Guidelines FLAG-Ida null N 220030337 FLAG + IDARUBICIN
220006456 220002488 1.75 115.9 Curative (C) 2013-04-05 2013-04-12 AML 19 TRIAL Y N 220030337 AML19 TRIAL
220006457 220002488 null 90 Disease modification (D) 2017-01-25 2017-01-25 Nilotinib 02 N 220030337 NILOTINIB
220006458 220002488 1.6 null Adjuvant (A) 2014-09-18 2014-09-18 FLAG + Idarubicin null N 220030337 FLAG + IDARUBICIN
220006459 220002488 1.75 null Curative (C) 2013-07-12 2013-07-18 AML 19 TRIAL 01 N 220030337 AML19 TRIAL
220006460 220002488 1.68 68.4 Curative (C) 2014-07-15 2014-07-15 AML 19 TRIAL N N 220030337 AML19 TRIAL
220006461 220002488 null 76.4 Curative (C) 2016-11-18 2016-11-21 AML 19 TRIAL Y N 220030337 AML19 TRIAL
220006462 220002489 1.62 null Curative (C) 2014-11-14 2014-11-14 FLAG + Idarubicin 2 N 220030352 FLAG + IDARUBICIN
220006463 220002489 1.76 71.5 Curative (C) 2013-07-04 2013-07-04 FLAG + Idarubicin 2 N 220030352 FLAG + IDARUBICIN
220006464 220002490 1.5 55.7 Curative (C) 2016-10-09 2016-10-09 AML 19 TRIAL Y N 220030354 AML19 TRIAL
220006465 220002491 null 35.3 Curative (C) 2013-11-18 2013-11-19 AML MyeChild N N 220030357 NOT MATCHED
220006466 220002491 null 76 Curative (C) 2013-02-07 2013-02-08 AML 19 TRIAL 01 null 220030357 AML19 TRIAL
220006467 220002491 1.86 74.2 Curative (C) 2014-10-08 2014-10-08 AML 19 TRIAL 1 N 220030357 AML19 TRIAL
220006468 220002491 1.75 82.1 Curative (C) 2017-11-05 2017-11-07 Nilotinib 02 N 220030357 NILOTINIB
220006469 220002491 0 66.2 Disease modification (D) 2017-01-25 2017-01-28 Nilotinib 02 N 220030357 NILOTINIB
220006470 220002492 1.65 76.7 Curative (C) 2015-01-03 2015-01-03 AML 19 TRIAL Y N 220030366 AML19 TRIAL
220006471 220002492 1.84 65.3 Curative (C) 2014-02-18 2014-02-18 AML 19 TRIAL Y N 220030366 AML19 TRIAL
220006472 220002492 0 0 Disease modification (D) 2015-05-07 2015-05-07 Nilotinib N N 220030366 NILOTINIB
220006473 220002493 1.82 77 Curative (C) 2013-03-01 2013-03-01 AML 19 TRIAL Y N 220030369 AML19 TRIAL
220006474 220002493 1.53 null Curative (C) 2014-05-24 2014-05-27 FLAG + Idarubicin N N 220030369 FLAG + IDARUBICIN
220006475 220002494 1.74 null Curative (C) 2014-04-20 2014-04-20 AML 19 TRIAL Y N 220030379 AML19 TRIAL
220006476 220011427 null null null null 2014-10-16 Nilotinib 02 N 220030383 NILOTINIB
220006477 220002495 1.85 74 Curative (C) 2014-12-10 2014-12-14 AML 19 TRIAL N N 220030389 AML19 TRIAL
220006478 220002496 0 64 Disease modification (D) null 2013-05-24 Nilotinib N Y 220030391 NILOTINIB
220006479 220002496 null null Curative (C) 2013-01-18 2014-01-21 Nilotinib 02 N 220030391 NILOTINIB
220006480 220002496 1.58 97.2 Curative (C) 2014-05-17 2014-05-17 AML 19 TRIAL Y null 220030391 AML19 TRIAL
220006481 220002496 1.71 58.3 Curative (C) 2014-02-21 2014-02-20 AML 19 TRIAL Y N 220030391 AML19 TRIAL
220006482 220002496 0 0 Palliative (P) 2013-12-28 2013-12-28 AML MyeChild 01 A Mitozantrone/Cytarabine N N 220030391 NOT MATCHED
220006483 220002497 1.85 61.9 Curative (C) 2017-01-08 2017-01-08 AML Interim Guidelines FLAG-Ida N N 220030400 FLAG + IDARUBICIN
220006484 220002497 1.61 null Curative (C) 2015-09-23 2015-09-26 AML 19 TRIAL Y N 220030400 AML19 TRIAL
220006485 220002497 null null Curative (C) 2014-10-29 2014-10-29 Nilotinib N N 220030400 NILOTINIB
220006488 220002499 1.55 77 Curative (C) 2015-10-24 2015-10-25 AML 19 TRIAL Y N 220030413 AML19 TRIAL
220006489 220002499 null 83.7 Curative (C) 2013-08-21 2013-08-22 AML 19 TRIAL N N 220030413 AML19 TRIAL
220006490 220002500 null null Curative (C) 2017-06-07 2017-06-08 null N N 220030417 NOT MATCHED
220006491 220002500 0 15.8 Curative (C) 2011-08-29 2013-04-30 CML Dasatinib 02 N 220030417 NOT MATCHED
220006492 220002500 0 64 Adjuvant (A) 2016-09-12 2016-09-12 Nilotinib 02 N 220030417 NILOTINIB
220006493 220002501 null 12.8 Curative (C) 2013-08-22 2013-08-24 AML Interim Guidelines Y N 220030423 NOT MATCHED
220006494 220002501 null 86.5 Curative (C) 2013-04-13 2013-05-07 Nilotinib N N 220030423 NILOTINIB
220006495 220002502 null 80.4 Palliative (P) 2015-08-29 2015-08-29 Nilotinib 2 N 220030426 NILOTINIB
220006496 220002502 null 82 Curative (C) 2013-05-30 2013-12-11 Nilotinib 02 N 220030426 NILOTINIB
220006497 220002502 1.84 45.7 Curative (C) 2016-08-01 2016-08-02 AML 19 TRIAL Y N 220030426 AML19 TRIAL
220006498 220002503 null 0 Palliative (P) 2017-02-16 2017-02-19 Nilotinib 02 N 220030435 NILOTINIB
220006499 220002504 1.55 68.3 Curative (C) 2013-02-05 2013-02-09 AML 19 TRIAL 02 N 220030438 AML19 TRIAL
220006500 220011435 0 0 Disease modification (D) 2017-01-13 2017-01-27 Nilotinib N N 220030439 NILOTINIB